Congratulations to Dr. Elliman and his team at Orbsen Therapeutics for their nomination for Spin-Out Company Impact Award, an annual Knowledge Transfer Ireland Impact Award.
“We are honoured to be nominated for KTI Spin-out Company of the Year. It recognises the huge efforts made by our own research team and our network of research partners to move Orbcel to the clinic so efficiently. Also, we are grateful to NUI Galway for their support over the years. The TTO have been instrumental in our progress to this point and we continue to enjoy working with them.” – Dr. Elliman
You can read more here.